Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can increase the risk of autoimmune skin diseases, especially bullous pemphigoid.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

scINSIGHT accurately identifies cell clusters and gene patterns in complex data.

Microneedles can precisely deliver cancer treatments with fewer side effects.

The research showed how melanocytes develop, move, and respond to UV light, and their stem cells' role in hair color and skin cancer risk.

Chemistry42 effectively creates and optimizes new molecules for drug discovery.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Microneedles can improve skin disease treatment by delivering drugs directly through the skin.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

mTORC2 is crucial for healthy skin barrier by regulating lipids and filaggrin.

Vitamin D may help reduce thyroid antibodies and improve thyroid function in Hashimoto's Thyroiditis.

Developing human skin has immune cells with memory-like features.

A new mouse model effectively mimics vitiligo for research and drug testing.

Certain genetic variations in IL18 may increase the risk of alopecia areata in Koreans.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Extracellular vesicles can help repair and regenerate tissues with less risk of rejection.

Vitamin D might be involved in the development of alopecia areata and could help in its treatment.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

The protein interleukin-1 alpha helps regenerate hair follicles and increase stem cell growth in mice.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Understanding genetic variations in mice is crucial for studying skin, hair, or nail abnormalities.

No significant genetic link to alopecia areata was found in the Jordanian group.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.